UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Statement of Cash Flows
Net income	$ 5,556	$ 5,368
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	311	308
Amortization	1,376	1,273
(Gain) loss on investments	0	0
Provision for (recovery of) losses on accounts receivable	6	(1)
(Gain)/Loss on disposal of assets	4	(1)
Deferred income taxes	(282)	(357)
Stock-based compensation expense	24	14
Changes in operating assets and liabilities:
Accounts receivable	(1,016)	(1,350)
Accrued interest and other receivables	(31)	(128)
Inventories	(472)	8
Prepaid expenses and other current assets	118	145
Accounts payable	91	(17)
Accrued expenses	75	169
Deferred revenue	0	(50)
Other liability	0	(339)
Total adjustments	203	(326)
Net cash provided by operating activities	5,760	5,042
Capital expenditures for property and equipment	(836)	(111)
Capital expenditures for intangible assets	0	(5)
Purchases of investments	0	0
Proceeds from sale of investments	0	0
Net cash provided by (used in) investing activities	(836)	(116)
Proceeds from issuance of common stock - options	271	490
Common stock purchased and retired	(818)	0
Payment of taxes for exchange of stock options	0	(90)
Tax benefit attributable to exercise of stock options	120	199
Repayment of notes payable	(2,035)	(1,935)
Payment of dividends	(938)	(911)
Net cash provided by (used in) financing activities	(3,401)	(2,246)
Effect of exchange rate changes on cash	20	(164)
Net increase in cash and cash equivalents	1,544	2,514
Cash at beginning of period	14,395	8,871
Cash at end of period	15,939	11,385
Cash paid during the period for income taxes	1,551	1,634
Cash paid during the period for interest	$ 167	$ 235